Skip Navigation


Hum. Reprod. Advance Access originally published online on April 29, 2009
Human Reproduction 2009 24(8):1960-1967; doi:10.1093/humrep/dep115
This Article
Right arrow Full Text
Right arrow Full Text (PDF )
Right arrow All Versions of this Article:
24/8/1960    most recent
dep115v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Polotsky, A. J.
Right arrow Articles by Pollard, J. W.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Polotsky, A. J.
Right arrow Articles by Pollard, J. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Lithium chloride treatment induces epithelial cell proliferation in xenografted human endometrium

Alex J. Polotsky1,2, Liyin Zhu3, Nanette Santoro1,2,4 and Jeffrey W. Pollard1,2,3,5

1 Department of Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine (AECOM), Bronx, NY, USA 2 Center for the Study of Reproductive Biology and Women's Health, Albert Einstein College of Medicine (AECOM), Bronx, NY, USA 3 Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA 4 Department of Medicine, Albert Einstein College of Medicine (AECOM), Bronx, NY, USA

5 Correspondence address. Tel: +1-718-430-2090; Fax: +1-718-430-8972; E-mail: pollard{at}aecom.yu.edu

BACKGROUND: In mouse endometrium, glycogen synthase kinase-3ß (GSK3ß) is a key enzyme controlling nuclear localization of cyclin D1. We developed a functional model of xenografted human endometrium to test whether similar mechanisms are operative in the human by using Lithium chloride (LiCl), an inhibitor of GSK3ß.

METHODS: Human endometrial samples were obtained from normal volunteers, then implanted under the kidney capsule of nude mice, and treated with estradiol-17ß (E2) or LiCl. Xenografts were assessed for protein expression of MKI-67, mini-chromosome maintenance protein-2, estrogen receptor (ER), progesterone receptor (PR) and cyclin D1.

RESULTS: Both E2 and LiCl induced a robust proliferative response in the epithelium. Only lithium treatment produced clear nuclear localization of cyclin D1 consistent with the proliferative response observed. Regenerated endometrium had detectable ER and PR expression.

CONCLUSION: Xenografted human endometrium provides a dynamic model of uterine biology. Administration of LiCl in the absence of E2 induced epithelial proliferation, supporting the hypothesis that human and murine endometrial proliferation may share key regulatory pathways. These data suggest a possible link between the increased menstrual disturbances in women with affective disorders taking lithium and the consequent potential for the development of endometrial proliferative disorder.

Key words: estrogen/progesterone/cell cycle/endometrium/lithium

Submitted on November 11, 2008; resubmitted on March 30, 2009; accepted on April 6, 2009.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.